ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.89
-0.24%
US Tech 100
20,618.80
0.03%
S&P 500
6,047.15
0.81%
US Dollar vs CAD
1.40264
-0.13%
Bitcoin
95,347.97
-0.54%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Immatics NV (4A3) Share Price

Immatics NV

Immatics NV (4A3)

TG
8.005
0.095
( 1.20% )
Updated: 04:31:18
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
8.005
Bid
7.885
Ask
8.08
Volume
1,683
7.80 Day's Range 8.02
7.14 52 Week Range 12.60
Market Cap
825.396M
Previous Close
7.91
Open
8.02
Last Trade
250
@
8.005
Last Trade Time
04:03:33
Financial Volume
-
VWAP
-
Average Volume (3m)
4,915
Shares Outstanding
103,110,000
Dividend Yield
-
PE Ratio
-8.84
Earnings Per Share (EPS)
-0.94
Revenue
55.14M
Net Profit
-96.99M

About Immatics NV

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Website
www.immatics.com
Headquarters
Tubingen, Deu
Founded
-
Immatics NV is listed in the Health & Allied Services sector of the Tradegate (DE) with ticker 4A3. The last closing price for Immatics NV was 7.91 €. Over the last year, Immatics NV shares have traded in a share price range of 7.14 € to 12.60 €.

Immatics NV currently has 103,110,000 shares outstanding. The market capitalization of Immatics NV is 815.60 € million. Immatics NV has a price to earnings ratio (PE ratio) of -8.84.

Ask ADVFN Intelligence (AI)

4A3 Latest News

More News

Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME

Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME The Company will now target five major cancer types with its four...

November 18 2024
UK Regulatory

Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME

Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME  Two oral presentations and...

November 08 2024
UK Regulatory

Immatics Announces Pricing of $150 Million Public Offering

Immatics Announces Pricing of $150 Million Public Offering Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical...

October 10 2024
UK Regulatory

Immatics Announces Proposed $150 Million Public Offering

Immatics Announces Proposed $150 Million Public Offering Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical...

October 10 2024
UK Regulatory

Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial

Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial Company to host conference...

October 10 2024
UK Regulatory

Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024

Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024 Houston, Texas and Tuebingen, Germany, October 4, 2024 – Immatics N.V...

October 04 2024
UK Regulatory

Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update

Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development...

September 16 2024
UK Regulatory

Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024

Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024 Houston, Texas and Tuebingen, Germany, September 06, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”...

September 06 2024
UK Regulatory

Immatics Announces Second Quarter 2024 Financial Results and Business Update

Immatics Announces Second Quarter 2024 Financial Results and Business Update Clinical data from May 2024 on ACTengine® IMA203 targeting PRAME in 30 heavily pre-treated metastatic melanoma patients...

August 13 2024
UK Regulatory

Immatics Appoints Alise Reicin to Board of Directors

Immatics Appoints Alise Reicin to Board of Directors Houston, Texas and Tuebingen, Germany, July 31, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage...

July 31 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.486.378737541537.5258.1357.23563857.84494785DE
4-0.595-6.918604651168.69.2157.1454527.84625609DE
12-2.945-26.894977168910.9511.77.1449159.09347097DE
26-1.93-19.42627075999.93512.67.1434319.87596844DE
52-0.375-4.474940334138.3812.67.14321310.10546287DE
156-2.395-23.028846153810.413.26.1529879.92601953DE
260-2.635-24.76503759410.6413.26.1529299.92606547DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
Y920Trilogy AI Corp
0.049 €
(75.00%)
1.34k
VJFVital Metals Ltd
0.0018 €
(50.00%)
200.89k
1UR1Bee Vectoring Technologies International Inc
0.0075 €
(36.36%)
37k
1EXEXMAR NV
11.18 €
(28.21%)
8.99k
UUDASyntara Ltd
0.0465 €
(25.68%)
3k
CNWCodon AG
0.006 €
(-45.45%)
5k
RUOCOcean Power Technologies
0.4095 €
(-37.19%)
1.34M
BDDConico Ltd
0.0004 €
(-33.33%)
1.25k
AXIAtos SE
0.47 €
(-32.39%)
1.92M
BR00Cruz Battery Metals Corp
0.0174 €
(-32.03%)
13.5k
PF8European Lithium Limited
0.0394 €
(25.48%)
5.88M
D7GNel ASA
0.2473 €
(-2.25%)
3.37M
REBArafura Rare Earths Ltd
0.0745 €
(-1.97%)
1.96M
AXIAtos SE
0.47 €
(-32.39%)
1.92M
RUOCOcean Power Technologies
0.4095 €
(-37.19%)
1.34M

Discussion

View Full Feed
Clark6290 Clark6290 5 minutes ago
Any proof, or just a guess or fake information
FNMA
Clark6290 Clark6290 6 minutes ago
Why are you so mean. I cannot help if your GSE stock is deep red my amigo
FNMA
gregcod gregcod 6 minutes ago
I cant wait to hear what the big surprise is here jancik said she will reveal..Burba is supposed to be there too?
IBATF
Edward Edward 8 minutes ago
Extremely strong this morning .

CTOR is up 61.76% @ 5:21am with heavy volume,

As of now no news as to what is the catalyst for the rise and interest.
CTOR
doc063 doc063 9 minutes ago
News today!?
RNVA
Edward Edward 9 minutes ago
Extremely strong this morning .

CTOR is up 61.76% @ 5:21am with heavy volume trading at $1.65.

As of now no news as to what is the catalyst for the rise and interest.
CTOR
ksquared ksquared 10 minutes ago
Nobody's buying it...
https://nypost.com/wp-content/uploads/sites/2/2024/12/DECEMBER03.P1_LCF.jpg?resize=400,441&quality=90&strip=all&w=750
MiamiGent MiamiGent 12 minutes ago
It's outrageous!
We ought to have a national sales tax and no filing.
Trump ought to do this immediately following Elon and Vivick firing 80% of the bloated federal bureaucracy.
pepeoil pepeoil 14 minutes ago
Maybe old Ronny Loudan and Holcomb could give old joshy one of those fake generators for his yacht and Asre could join the scam merger. They could hire bubbie and Jamie from Vyst to keep the books and bring them into the scam. Don’t forget old Jack hanks at mmex, he can build old joshy a huge re
Extremist223 Extremist223 14 minutes ago
MHRA did not complete a rapid review of DCVAX right? How long do you expect the normal review to take?
NWBO
luvwetscent luvwetscent 17 minutes ago
Could be another bashturd lurking just below the surface...God, save his soul.
ELTP
pepeoil pepeoil 19 minutes ago
Old Peter Maxwell continues to post “Good morning Shrimpers “ on his Facebook scam page for Shmp, even though they are in receivership. Bwahaaaaaaa. Shmp and Joshy should get together and merge their scams and call it scam incorporated. They could use old lying joshys yacht as a shrimp boa
TRUISM TRUISM 20 minutes ago
Kraig Biocraft Laboratories, Inc. · Full-time
Senior Scientist
Jul 2021 - Jul 2024 · 3 yrs 1 mo

•Developed and cloned piggyBac plasmids encoding spider silk genes to be expressed in silkworms for the production of spider silk.
•Successfully PCR amplified highl
KBLB
ksquared ksquared 21 minutes ago
Why meteorological and astronomical winter start on 2 different dates
Many people consider the December solstice to be the official start of winter, but for meteorologists, the new season kicks off weeks before the astronomical event.
By Monica Danielle, AccuWeather Managing Editor Upd
SilkRoad SilkRoad 21 minutes ago
I think the conversation between Larry and Kim would go something like this….

Larry: When is the web conference?

Kim: Soon. I’ll let you know right before the event.

Larry: Are you sure?

Kim: Yeah.

::: staredown:::
KBLB
chicks0123 chicks0123 22 minutes ago
Good morning CLNVers 
CLNV
Moonboy1 Moonboy1 22 minutes ago
Looks like it's trying to move a little bit.
MLGO
tradernewstip tradernewstip 27 minutes ago
$CBDW The AI Chatbot Market in 2025: Growth Prospects and the Strategic Expansion of 1606 Corporation (CBDW)
@2desire-growth-prospects-and-the-strategic-expansion-of-1606-corporation-cbdw/
CBDW
mwab52 mwab52 28 minutes ago
Good morning (RNVA-Land & Team).......🤑😎........ Go (RNVA & Team)
RNVA
RichieBoy RichieBoy 36 minutes ago
Did you see where Contrivian received another very prestigious award from the IT industry? Usually holding companies are existential conduits for high net worth individuals. Long shot I know but, you don't suppose Michael Balkin has any connections with Durham Black or whatever Patrick Shutt calls h
AFFU
tradernewstip tradernewstip 38 minutes ago
$ILLR News : Creator-Centric Triller: Sean Kim's Strategy for Social Platform Success
Los Angeles, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Triller Group Inc. (Nasdaq: ILLR) ("Triller Group" or "the Company") revealed a momentous milestone in its evolution by introducing the latest iteration of Tril
ILLR
IB_ IB_ 43 minutes ago
What ya think ??????????

IB_🤴
SXOOF
IB_ IB_ 43 minutes ago
What ya think ??????????

IB_🤴
SXOOF
CanItBThisEZ2Make CanItBThisEZ2Make 43 minutes ago
BEST SELLERS RANK (BSR) IS 490 56 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX

Your Recent History

TG
4A3
Immatics NV
TG
YPH
Astellas Pharma
USOTC
GKOTF
Geekco Technologies (PK)
ASX
KFWHN
KFW
AQEU
PGND
Paragon GmbH & Co KGaA
ASX
VIAN
Viagold Capital
USOTC
GYST
Graystone (PK)
USOTC
USGDF
American Pacific Mining (QX)
ASX
ASNNC
Anson Resources
TG
ZOE
Zoetis
TG
C6V
Headwater Exploration
TG
3NTA
Navios Maritime
TG
HIFH
Cosco Shipping Energy Tr...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved